Mary Jo Staruch - Concepedia

Concepedia

Author

Mary Jo Staruch

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

J B Smith, M J Staruch, M. J. STARUCH, M.J. Staruch, MARY JO STARUCH, Mary Jo Staruch

42

Publications

3.2K

Citations

23

H-Index

54

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Harvard University

MJ

About

Mary Jo Staruch is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.7K
2	Natural Sciences	5	5	149
3	Biochemistry	4	4	351
4	Allergy	1	1	187
5	Biomolecular Engineering	1	1	37

Mary Jo Staruch

×

30

Publications

3.2K

Citations

23

H-Index

	Year	Citations
Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. Francis J. Dumont, Mary Jo Staruch, Sam L. Koprak, The Journal of Immunology	1990	607
The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. Francis J. Dumont, Michael Melino, Mary Jo Staruch, The Journal of Immunology	1990	355
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. Francis J. Dumont, Mary Jo Staruch, Sam L. Koprak, The Journal of Experimental Medicine ImmunotoxicologyToxic EffectsImmunologyCell DeathPharmacotherapy	1992	253
Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? N H Sigal, Francis J. Dumont, P. L. DURETTE, The Journal of Experimental Medicine Major Cytosolic ProteinImmunologyCyclosporin AInflammationNephrotoxic Mechanism	1991	249
Binding and Functional Properties of Recombinant and Endogenous CXCR3 Chemokine Receptors Youmin Weng, Salvatore Siciliano, K E Waldburger, Journal of Biological Chemistry	1998	215
The adjuvanticity of interleukin 1 <i>in vivo</i>. Mary Jo Staruch, David D. Wood The Journal of Immunology	1983	193
Inhibition of T Cell Activation by Pharmacologic Disruption of the MEK1/ERK MAP Kinase or Calcineurin Signaling Pathways Results in Differential Modulation of Cytokine Production Francis J. Dumont, Mary Jo Staruch, Paul Fischer, The Journal of Immunology T-regulatory CellImmunologyImmune RegulationCell DeathSignaling Pathways	1998	187
CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T Cells Irwin Singer, Solomon Scott, D W Kawka, Journal of Virology ImmunologyImmunodominanceAntigen ProcessingCd4 T Cell ResponsesT Cells	2001	160
FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin. John J. Siekierka, Mary Jo Staruch, Shih‐Han Hung, The Journal of Immunology Microbial PathogensNovel MacrolideImmunologyImmunologic MechanismAntigen Processing	1989	140
The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities. David D. Wood, E K Bayne, Mary B. Goldring, The Journal of Immunology InflammationCytokineDistinct SpeciesPorcine ReceptorLaf Activity	1985	112

Page 1